Related Experiment Video
Updated: Jul 5, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
A Longitudinal Study of a Selected Pediatric Asthmatic Population with Normal and Abnormal Spirometry at Baseline: An
Sornsiri Yimlamai1, Kanokpan Ruangnapa1, Wanaporn Anuntaseree1
1Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, 90110, Thailand.
Insights
In children with asthma, abnormal spirometry results were common but did not predict poor outcomes. Adjusting asthma controllers based on symptoms or spirometry yielded similar long-term disease control.
Area of Science:
- Pediatric Pulmonology
- Asthma Management
- Clinical Research
Background:
- Asthma control in children often relies on clinical assessment.
- The role of spirometry in guiding asthma controller adjustments in pediatric populations is not well-established.
- Limited pediatric studies exist on using abnormal spirometry for disease management.
Purpose of the Study:
- To determine the prevalence of abnormal spirometry in children with asthma.
- To evaluate the impact of abnormal spirometry on longitudinal asthma outcomes.
- To assess if spirometry aids in adjusting asthma controller medications in children.
Main Methods:
- Retrospective cohort study at Songklanagarind Hospital, Thailand.
- Included children (<18 years) with asthma and spirometry with bronchodilator responsiveness (BDR) tests.
- Analyzed differences in outcomes between normal and abnormal spirometry groups over 12 months.
Main Results:
- Abnormal spirometry (airflow limitation or BDR) was found in 58.1% of 203 pediatric asthma patients.
- No significant differences in baseline characteristics, atopy, treatment, or outcomes between spirometry groups.
- Adjustments based on spirometry or symptoms led to comparable 12-month disease control.
Conclusions:
- Abnormal spirometry is prevalent in treated school-aged children with asthma.
- Abnormal spirometry did not correlate with poorer asthma outcomes in the follow-up period.
- Symptom-based and spirometry-based controller adjustments achieved similar asthma control.
Purpose:
It is still unclear whether considering abnormal spirometry as a marker for disease control can help physicians adjust asthma controllers in children because of the scarcity of pediatric studies. We aimed to investigate the prevalence of abnormal spirometry in a selected pediatric asthmatic population and its effect on longitudinal outcomes.
Patients And Methods:
This retrospective cohort study was conducted at the Songklanagarind Hospital, Thailand. Children with asthma aged <18 years were recruited for review if they attended the clinic and underwent acceptable spirometry with bronchodilator responsiveness (BDR) tests after receiving asthma treatment for at least 3 months between January 2011 and June 2022. Differences in baseline characteristics, atopic factors, asthma treatment, and outcomes were analyzed between the normal and abnormal spirometry groups over a 12-month post-spirometry period.
Results:
The mean age of the 203 enrolled patients was 10.9 ± 2.6 years. Abnormal spirometry, defined as airflow limitation or the presence of BDR, was observed in 58.1% of patients. No significant differences were observed in baseline characteristics, atopic factors, asthma treatment, or outcomes between the normal and abnormal spirometry groups. Further analysis of 107 patients with abnormal spirometry with symptom control revealed that physicians adjusted the asthma controller based on spirometry and symptoms in 84 and 23 patients, respectively. There was no significant difference in the loss of disease control over the 12-month post-spirometry period between the two groups.
Conclusion:
Abnormal spirometry was found in 58.1% of treated school-aged patients with asthma. Abnormal spirometry results were not associated with poor asthma outcomes during the 12-month follow-up. Both symptom-based and spirometry-based adjustments of asthma controllers resulted in comparable symptom control over a 12-month follow-up period in the selected population.
Related Concept Videos
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Asthma-III: Symptoms and Complications
Classification of Asthma
Longitudinal Research
COPD: Management Using Bronchodilators and Corticosteroids

